Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  entinostat
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00220, CDR0000504083, NA_00003114, J0658, 7759, P30CA006973, U01CA070095, JHOC-J0658, NCT00387465

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SNDX-275-0401, NCT00602030

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01077, E1905, U10CA021115, ECOG-E1905, NCT00313586

4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00195, J06114, U01CA070095, JHOC-J06114, 7605, NA_00006989, NCT00462605

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SNDX-275-0301, NCT00676663

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: SNDX-275-0403, NCT00750698

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: SNDX-275-0303, NCT00828854

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SNDX-275-0501, NCT00866333

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-02024, CDR0000670136, MC084B, 8341, N01CM00099, P30CA015083, N01CM00038, MAYO-MC084B, NCT01105377

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: J1093, NCT01305499

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02585, CDR0000698726, SKCCC J1107, 8822, P30CA006973, N01CM00038, N01CM62205, U01CA070095, U01CA062505, MAYO-MC1035, MC1035, NCT01349959

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068574, J0253, U01CA069854, P30CA006973, JHOC-J0253, MSGCC-0050, NCI-2791, NCT00015925

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02634, JHOC-J0438, U01CA070095, CDR0000396776, 6798, NCI-6798, JHOC-04060103, NCT00098891

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00071, CDR0000405841, J0443, 6591, U01CA070095, P30CA006973, JHOC-J0443, NCI-6591, JHOC-04061109, NCT00101179

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01436, CDR0000671796, JHOC-MD017, J09112, 8298, U01CA070095, P30CA006973, SKCCC-MD017, NCT01132573

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: SNDX-275-0110, NCT01594398

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, NIH WGMCC
Protocol IDs: 010124, 01-C-0124, NCI-2792, CDR0000068615, NCI-01-C-0124, 2792, NCT00020579
New Search